{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:46:20Z","timestamp":1791996380438,"version":"4.4.0"},"reference-count":152,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":111,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Breast Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This narrative review explores the latest advancements in various imaging modalities combined with artificial intelligence (AI) for monitoring response to neoadjuvant therapy (NT) and predicting pathological complete response (pCR). We provide a detailed analysis of the principles, evaluation metrics, strengths, and limitations of each technique. The integration of multimodal imaging and AI is reshaping the paradigm for evaluating NT efficacy in breast cancer, offering robust support for precision medicine.<\/jats:p>","DOI":"10.1038\/s41523-026-00995-0","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T17:14:33Z","timestamp":1782321273000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multimodal imaging and artificial intelligence for response assessment to neoadjuvant therapy in breast cancer: a comprehensive review"],"prefix":"10.1038","volume":"12","author":[{"given":"Linlin","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangbo","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yansong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"995_CR1","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1200\/JCO.20.03399","volume":"39","author":"LA Korde","year":"2021","unstructured":"Korde, L. A. et al. Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline. J. Clin. Oncol. 39, 1485\u20131505 (2021).","journal-title":"J. Clin. Oncol."},{"key":"995_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.annonc.2023.11.016","volume":"35","author":"S Loibl","year":"2024","unstructured":"Loibl, S. et al. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann. Oncol. 35, 159\u2013182 (2024).","journal-title":"Ann. Oncol."},{"key":"995_CR3","doi-asserted-by":"publisher","first-page":"426","DOI":"10.6004\/jnccn.2025.0053","volume":"23","author":"WJ Gradishar","year":"2025","unstructured":"Gradishar, W. J. et al. NCCN Guidelines\u00ae Insights: breast cancer, version 5.2025. J. Natl. Compr. Cancer Netw. 23, 426\u2013436 (2025).","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"995_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53450-8","volume":"15","author":"Y Gao","year":"2024","unstructured":"Gao, Y. et al. An explainable longitudinal multi-modal fusion model for predicting neoadjuvant therapy response in women with breast cancer. Nat. Commun. 15, 9613 (2024).","journal-title":"Nat. Commun."},{"key":"995_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","volume":"384","author":"P Cortazar","year":"2014","unstructured":"Cortazar, P. et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet 384, 164\u2013172 (2014).","journal-title":"Lancet"},{"key":"995_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1570394","volume":"16","author":"X Chen","year":"2025","unstructured":"Chen, X. et al. Pathological complete response and prognostic predictive factors of neoadjuvant chemoimmunotherapy in early stage triple-negative breast cancer. Front. Immunol. 16, 1570394 (2025).","journal-title":"Front. Immunol."},{"key":"995_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-03020-z","volume":"19","author":"F Li","year":"2021","unstructured":"Li, F. et al. Deep learning-based predictive biomarker of pathological complete response to neoadjuvant chemotherapy from histological images in breast cancer. J. Transl. Med. 19, 348 (2021).","journal-title":"J. Transl. Med."},{"key":"995_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2021.103309","volume":"160","author":"N Gennaro","year":"2021","unstructured":"Gennaro, N. et al. Imaging response evaluation after neoadjuvant treatment in soft tissue sarcomas: where do we stand? Crit. Rev. Oncol. Hematol. 160, 103309 (2021).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"995_CR9","doi-asserted-by":"publisher","first-page":"5423","DOI":"10.1007\/s00330-023-09547-7","volume":"33","author":"R Ploumen","year":"2023","unstructured":"Ploumen, R. et al. Imaging findings for response evaluation of ductal carcinoma in situ in breast cancer patients treated with neoadjuvant systemic therapy: a systematic review and meta-analysis. Eur. Radiol. 33, 5423\u20135435 (2023.","journal-title":"Eur. Radiol."},{"key":"995_CR10","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.annonc.2024.02.002","volume":"35","author":"L Pusztai","year":"2024","unstructured":"Pusztai, L. et al. Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522. Ann. Oncol. 35, 429\u2013436 (2024).","journal-title":"Ann. Oncol."},{"key":"995_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/annonc\/mdy547","volume":"30","author":"SJ Luen","year":"2019","unstructured":"Luen, S. J. et al. Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy. Ann. Oncol. 30, 236\u2013242 (2019).","journal-title":"Ann. Oncol."},{"key":"995_CR12","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer, E. A. et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur. J. Cancer 45, 228\u2013247 (2009).","journal-title":"Eur. J. Cancer"},{"key":"995_CR13","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1097\/SLA.0000000000004356","volume":"273","author":"S Samiei","year":"2021","unstructured":"Samiei, S. et al. Diagnostic performance of noninvasive imaging for assessment of axillary response after neoadjuvant systemic therapy in clinically node-positive breast cancer: a systematic review and meta-analysis. Ann. Surg. 273, 694\u2013700 (2021).","journal-title":"Ann. Surg."},{"key":"995_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10549-024-07548-8","volume":"210","author":"R Rella","year":"2025","unstructured":"Rella, R. et al. Association between mammographic breast density and outcome in patients with unilateral invasive breast cancer receiving neoadjuvant chemotherapy. Breast Cancer Res. Treat. 210, 157\u2013166 (2025).","journal-title":"Breast Cancer Res. Treat."},{"key":"995_CR15","doi-asserted-by":"publisher","first-page":"5986","DOI":"10.1007\/s00330-022-08751-1","volume":"32","author":"J-X Huang","year":"2022","unstructured":"Huang, J.-X. et al. Combining conventional ultrasound and sonoelastography to predict axillary status after neoadjuvant chemotherapy for breast cancer. Eur. Radiol. 32, 5986\u20135996 (2022).","journal-title":"Eur. Radiol."},{"key":"995_CR16","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1080\/02648725.2023.2191087","volume":"40","author":"C Lv","year":"2024","unstructured":"Lv, C., Yan, C., Xiang, C. & Yu, L. Predictive value of acoustic radiation force impulse imaging in breast cancer after neoadjuvant chemotherapy. Biotechnol. Genet. Eng. Rev. 40, 976\u2013986 (2024).","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"995_CR17","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.240138","volume":"7","author":"AP Sinha","year":"2025","unstructured":"Sinha, A. P. et al. Tumor biomechanics quantified using MR elastography to predict response to neoadjuvant chemotherapy in individuals with breast cancer. Radiol. Imaging Cancer 7, e240138 (2025).","journal-title":"Radiol. Imaging Cancer"},{"key":"995_CR18","doi-asserted-by":"publisher","first-page":"9557","DOI":"10.7150\/thno.64767","volume":"11","author":"A Rix","year":"2021","unstructured":"Rix, A. et al. Effects of contrast-enhanced ultrasound treatment on neoadjuvant chemotherapy in breast cancer. Theranostics 11, 9557\u20139570 (2021).","journal-title":"Theranostics"},{"key":"995_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105311","volume":"107","author":"Z Li","year":"2024","unstructured":"Li, Z. et al. Multiregional dynamic contrast-enhanced MRI-based integrated system for predicting pathological complete response of axillary lymph node to neoadjuvant chemotherapy in breast cancer: multicentre study. EBioMedicine 107, 105311 (2024).","journal-title":"EBioMedicine"},{"key":"995_CR20","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1148\/radiol.2018180273","volume":"289","author":"SC Partridge","year":"2018","unstructured":"Partridge, S. C. et al. Diffusion-weighted MRI findings predict pathologic response in neoadjuvant treatment of breast cancer: the ACRIN 6698 multicenter trial. Radiology 289, 618\u2013627 (2018).","journal-title":"Radiology"},{"key":"995_CR21","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1364\/BOE.515135","volume":"15","author":"Y Li","year":"2024","unstructured":"Li, Y., Zhang, Y., Yu, Q., He, C. & Yuan, X. Intelligent scoring system based on dynamic optical breast imaging for early detection of breast cancer. Biomed. Opt. Express 15, 1515\u20131527 (2024).","journal-title":"Biomed. Opt. Express"},{"key":"995_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06153-7","volume":"23","author":"RC Lee","year":"2025","unstructured":"Lee, R. C., Boparai, M. S. & Duong, T. Q. Detection of breast cancer lesions using APT weighted MRI: a systematic review. J. Transl. Med. 23, 141 (2025).","journal-title":"J. Transl. Med."},{"key":"995_CR23","doi-asserted-by":"publisher","first-page":"6004","DOI":"10.1158\/0008-5472.CAN-21-1499","volume":"81","author":"R Woitek","year":"2021","unstructured":"Woitek, R. et al. Hyperpolarized carbon-13 MRI for early response assessment of neoadjuvant chemotherapy in breast cancer patients. Cancer Res. 81, 6004\u20136017 (2021).","journal-title":"Cancer Res."},{"key":"995_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-020-01350-2","volume":"22","author":"S Han","year":"2020","unstructured":"Han, S. & Choi, J. Y. Prognostic value of 18F-FDG PET and PET\/CT for assessment of treatment response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis. Breast Cancer Res. 22, 119 (2020).","journal-title":"Breast Cancer Res."},{"key":"995_CR25","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1053\/j.semnuclmed.2024.09.003","volume":"54","author":"A Al-Ibraheem","year":"2024","unstructured":"Al-Ibraheem, A., Abdlkadir, A. S., Shi, H., Abdel-Razeq, H. & Mansour, A. PET\/CT assessment of estrogen receptor positivity for breast cancer using [68Ga]Ga-RM2 bombesin receptor antagonist: a systematic review and meta-analysis. Semin. Nucl. Med. 54, 896\u2013903 (2024).","journal-title":"Semin. Nucl. Med."},{"key":"995_CR26","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1109\/TBME.2024.3383920","volume":"71","author":"P Karwat","year":"2024","unstructured":"Karwat, P., Piotrzkowska-Wr\u00f3blewska, H., Klimonda, Z., Dobruch-Sobczak, K. S. & Litniewski, J. Monitoring breast cancer response to neoadjuvant chemotherapy using probability maps derived from quantitative ultrasound parametric images. IEEE Trans. Biomed. Eng. 71, 2620\u20132629 (2024).","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"995_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-025-00661-8","volume":"20","author":"E Krasniqi","year":"2025","unstructured":"Krasniqi, E. et al. Multimodal deep learning for predicting neoadjuvant treatment outcomes in breast cancer: a systematic review. Biol. Direct 20, 72 (2025).","journal-title":"Biol. Direct"},{"key":"995_CR28","doi-asserted-by":"publisher","first-page":"188864","DOI":"10.1016\/j.bbcan.2023.188864","volume":"1878","author":"X Zhao","year":"2023","unstructured":"Zhao, X., Bai, J.-W., Guo, Q., Ren, K. & Zhang, G.-J. Clinical applications of deep learning in breast MRI. Biochim. Biophys. Acta Rev. Cancer 1878, 188864 (2023).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"995_CR29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/JS9.0000000000002105","volume":"111","author":"J-X Huang","year":"2025","unstructured":"Huang, J.-X. et al. Elastography-based AI model can predict axillary status after neoadjuvant chemotherapy in breast cancer with nodal involvement: a prospective, multicenter, diagnostic study. Int. J. Surg. 111, 221\u2013229 (2025).","journal-title":"Int. J. Surg."},{"key":"995_CR30","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1148\/radiol.2019182947","volume":"292","author":"RM Mann","year":"2019","unstructured":"Mann, R. M., Cho, N. & Moy, L. Breast MRI: state of the art. Radiology 292, 520\u2013536 (2019).","journal-title":"Radiology"},{"key":"995_CR31","doi-asserted-by":"publisher","first-page":"066001","DOI":"10.1117\/1.JBO.29.6.066001","volume":"29","author":"B Deng","year":"2024","unstructured":"Deng, B. et al. Functional hemodynamic imaging markers for the prediction of pathological outcomes in breast cancer patients treated with neoadjuvant chemotherapy. J. Biomed. Opt. 29, 066001 (2024).","journal-title":"J. Biomed. Opt."},{"key":"995_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-023-01607-6","volume":"25","author":"MV Pavlov","year":"2023","unstructured":"Pavlov, M. V. et al. Changes in the tumor oxygenation but not in the tumor volume and tumor vascularization reflect early response of breast cancer to neoadjuvant chemotherapy. Breast Cancer Res. 25, 12 (2023).","journal-title":"Breast Cancer Res."},{"key":"995_CR33","doi-asserted-by":"publisher","first-page":"5933","DOI":"10.1158\/0008-5472.CAN-16-0346","volume":"76","author":"BJ Tromberg","year":"2016","unstructured":"Tromberg, B. J. et al. Predicting responses to neoadjuvant chemotherapy in breast cancer: ACRIN 6691 trial of diffuse optical spectroscopic imaging. Cancer Res. 76, 5933\u20135944 (2016).","journal-title":"Cancer Res."},{"key":"995_CR34","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1001\/jama.2012.388","volume":"307","author":"WA Berg","year":"2012","unstructured":"Berg, W. A. et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA 307, 1394\u20131404 (2012).","journal-title":"JAMA"},{"key":"995_CR35","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","volume":"30","author":"S Filetti","year":"2019","unstructured":"Filetti, S. et al. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020. Ann. Oncol. 30, 1856\u20131883 (2019).","journal-title":"Ann. Oncol."},{"key":"995_CR36","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3350\/cmh.2018.1013","volume":"25","author":"H Maruyama","year":"2019","unstructured":"Maruyama, H. & Kato, N. Advances in ultrasound diagnosis in chronic liver diseases. Clin. Mol. Hepatol. 25, 160\u2013167 (2019).","journal-title":"Clin. Mol. Hepatol."},{"key":"995_CR37","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1001\/jama.2012.388","volume":"307","author":"Z Zhang","year":"2012","unstructured":"Zhang, Z. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA 307, 1394\u20131404 (2012).","journal-title":"JAMA"},{"key":"995_CR38","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.breast.2017.05.015","volume":"35","author":"A Peppe","year":"2017","unstructured":"Peppe, A., Wilson, R., Pope, R., Downey, K. & Rusby, J. The use of ultrasound in the clinical re-staging of the axilla after neoadjuvant chemotherapy (NACT). Breast 35, 104\u2013108 (2017).","journal-title":"Breast"},{"key":"995_CR39","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1002\/cncr.35248","volume":"130","author":"Q Zheng","year":"2024","unstructured":"Zheng, Q. et al. An ultrasound-based nomogram for predicting axillary node pathologic complete response after neoadjuvant chemotherapy in breast cancer: modeling and external validation. Cancer 130, 1513\u20131523 (2024).","journal-title":"Cancer"},{"key":"995_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.109170","volume":"130","author":"RP Candelaria","year":"2020","unstructured":"Candelaria, R. P. et al. Axillary ultrasound during neoadjuvant systemic therapy in triple-negative breast cancer patients. Eur. J. Radiol. 130, 109170 (2020).","journal-title":"Eur. J. Radiol."},{"key":"995_CR41","doi-asserted-by":"publisher","first-page":"4896","DOI":"10.1007\/s00330-025-11408-4","volume":"35","author":"C Malhaire","year":"2025","unstructured":"Malhaire, C. et al. Predicting axillary residual disease after neoadjuvant therapy in breast cancer using baseline MRI and ultrasound. Eur. Radiol. 35, 4896\u20134909 (2025).","journal-title":"Eur. Radiol."},{"key":"995_CR42","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1097\/JS9.0000000000000754","volume":"109","author":"Y Han","year":"2023","unstructured":"Han, Y. et al. The percentage of unnecessary mastectomy due to false size prediction using preoperative ultrasonography and MRI in breast cancer patients who underwent neoadjuvant chemotherapy: a prospective cohort study. Int. J. Surg. 109, 3993\u20133999 (2023).","journal-title":"Int. J. Surg."},{"key":"995_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-023-01756-8","volume":"26","author":"JI L\u00f3pez-Velazco","year":"2024","unstructured":"L\u00f3pez-Velazco, J. I. et al. A prospective study on tumour response assessment methods after neoadjuvant endocrine therapy in early oestrogen receptor-positive breast cancer. Breast Cancer Res. 26, 3 (2024).","journal-title":"Breast Cancer Res."},{"key":"995_CR44","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1016\/j.clbc.2021.05.010","volume":"22","author":"ME Hatzipanagiotou","year":"2022","unstructured":"Hatzipanagiotou, M. E. et al. Feasibility of ABUS as an alternative to handheld ultrasound for response control in neoadjuvant breast cancer treatment. Clin. Breast Cancer 22, e142\u2013e146 (2022).","journal-title":"Clin. Breast Cancer"},{"key":"995_CR45","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.ultrasmedbio.2023.03.017","volume":"49","author":"Y Xie","year":"2023","unstructured":"Xie, Y. et al. Early prediction of response to neoadjuvant chemotherapy using quantitative parameters on automated breast ultrasound combined with contrast-enhanced ultrasound in breast cancer. Ultrasound Med. Biol. 49, 1638\u20131646 (2023).","journal-title":"Ultrasound Med. Biol."},{"key":"995_CR46","first-page":"625","volume":"15","author":"W Jiang","year":"2023","unstructured":"Jiang, W., Deng, X., Zhu, T., Fang, J. & Li, J. ABVS-based radiomics for early predicting the efficacy of neoadjuvant chemotherapy in patients with breast cancers. Breast Cancer 15, 625\u2013636 (2023).","journal-title":"Breast Cancer"},{"key":"995_CR47","first-page":"103","volume":"72","author":"M Zemanov\u00e1","year":"2016","unstructured":"Zemanov\u00e1, M. New diagnostic imaging technique - shear wave elastography. Cesk Slov. Oftalmol. 72, 103\u2013110 (2016).","journal-title":"Cesk Slov. Oftalmol."},{"key":"995_CR48","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11547-024-01936-2","volume":"130","author":"J-X Huang","year":"2025","unstructured":"Huang, J.-X. et al. Enhancing detection of high-level axillary lymph node metastasis after neoadjuvant therapy in breast cancer patients with nodal involvement: a combined approach of axilla ultrasound and breast elastography. Radiol. Med. 130, 121\u2013131 (2025).","journal-title":"Radiol. Med."},{"key":"995_CR49","doi-asserted-by":"crossref","unstructured":"Karagiannis, G. S. et al. Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism. Sci. Transl. Med. 9, eaan0026 (2017).","DOI":"10.1126\/scitranslmed.aan0026"},{"key":"995_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1176141","volume":"13","author":"J Qi","year":"2023","unstructured":"Qi, J. et al. The potential role of combined shear wave elastography and superb microvascular imaging for early prediction the pathological response to neoadjuvant chemotherapy in breast cancer. Front. Oncol. 13, 1176141 (2023).","journal-title":"Front. Oncol."},{"key":"995_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-025-01978-y","volume":"27","author":"S Sabeti","year":"2025","unstructured":"Sabeti, S. et al. Ultrasound-based quantitative microvasculature imaging for early prediction of response to neoadjuvant chemotherapy in patients with breast cancer. Breast Cancer Res. 27, 24 (2025).","journal-title":"Breast Cancer Res."},{"key":"995_CR52","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1109\/TMI.2024.3405621","volume":"43","author":"F Chen","year":"2024","unstructured":"Chen, F. et al. Do as sonographers think: contrast-enhanced ultrasound for thyroid nodules diagnosis via microvascular infiltrative awareness. IEEE Trans. Med. Imaging 43, 3881\u20133894 (2024).","journal-title":"IEEE Trans. Med. Imaging"},{"key":"995_CR53","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1002\/jum.16143","volume":"42","author":"H Tai","year":"2023","unstructured":"Tai, H., Margolis, R., Li, J. & Hoyt, K. H-scan ultrasound monitoring of breast cancer response to chemotherapy and validation with diffusion-weighted magnetic resonance imaging. J. Ultrasound Med. 42, 1297\u20131306 (2023).","journal-title":"J. Ultrasound Med."},{"key":"995_CR54","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/mp.15428","volume":"49","author":"Z Klimonda","year":"2022","unstructured":"Klimonda, Z., Karwat, P., Dobruch-Sobczak, K., Piotrzkowska-Wr\u00f3blewska, H. & Litniewski, J. Assessment of breast cancer response to neoadjuvant chemotherapy based on ultrasound backscattering envelope statistics. Med. Phys. 49, 1047\u20131054 (2022).","journal-title":"Med. Phys."},{"key":"995_CR55","doi-asserted-by":"crossref","unstructured":"Shao, L. et al. Multimodal radiomics model with triple -timepoint contrast-enhanced ultrasound for precise diagnosis of C-TIRADS 4 thyroid nodules. BMC Med. Imaging 16, 1639017 (2025).","DOI":"10.3389\/fendo.2025.1639017"},{"key":"995_CR56","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.mayocp.2023.05.006","volume":"99","author":"V Anand","year":"2024","unstructured":"Anand, V. et al. Machine learning for diagnosis of pulmonary hypertension by echocardiography. Mayo Clin. Proc. 99, 260\u2013270 (2024).","journal-title":"Mayo Clin. Proc."},{"key":"995_CR57","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.3748\/wjg.v28.i27.3398","volume":"28","author":"LL Cao","year":"2022","unstructured":"Cao, L. L. et al. Artificial intelligence in liver ultrasound. World J. Gastroenterol. 28, 3398\u20133409 (2022).","journal-title":"World J. Gastroenterol."},{"key":"995_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04201-8","volume":"21","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. Noninvasive prediction of node-positive breast cancer response to presurgical neoadjuvant chemotherapy therapy based on machine learning of axillary lymph node ultrasound. J. Transl. Med. 21, 337 (2023).","journal-title":"J. Transl. Med."},{"key":"995_CR59","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10549-025-07727-1","volume":"212","author":"J Yao","year":"2025","unstructured":"Yao, J. et al. Machine learning prediction of pathological complete response to neoadjuvant chemotherapy with peritumoral breast tumor ultrasound radiomics: compare with intratumoral radiomics and clinicopathologic predictors. Breast Cancer Res. Treat. 212, 325\u2013336 (2025).","journal-title":"Breast Cancer Res. Treat."},{"key":"995_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110716","volume":"27","author":"J Yao","year":"2024","unstructured":"Yao, J. et al. Predicting axillary response to neoadjuvant chemotherapy using peritumoral and intratumoral ultrasound radiomics in breast cancer subtypes. iScience 27, 110716 (2024).","journal-title":"iScience"},{"key":"995_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1586715","volume":"15","author":"M Wang","year":"2025","unstructured":"Wang, M. et al. Comparative analysis of multi-zone peritumoral radiomics in breast cancer for predicting NAC response using ABVS-based deep learning models. Front. Oncol. 15, 1586715 (2025).","journal-title":"Front. Oncol."},{"key":"995_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-025-01971-5","volume":"27","author":"X Feng","year":"2025","unstructured":"Feng, X. et al. Predicting the efficacy of neoadjuvant chemotherapy in breast cancer patients based on ultrasound longitudinal temporal depth network fusion model. Breast Cancer Res. 27, 30 (2025).","journal-title":"Breast Cancer Res."},{"key":"995_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00678-8","volume":"8","author":"J Guo","year":"2024","unstructured":"Guo, J. et al. Cross-modal deep learning model for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer. npj Precis. Oncol. 8, 189 (2024).","journal-title":"npj Precis. Oncol."},{"key":"995_CR64","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1093\/oncolo\/oyad227","volume":"29","author":"J Gu","year":"2024","unstructured":"Gu, J. et al. Deep learning of multimodal ultrasound: stratifying the response to neoadjuvant chemotherapy in breast cancer before treatment. Oncologist 29, e187\u2013e197 (2024).","journal-title":"Oncologist"},{"key":"995_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2025.112105","volume":"187","author":"O Lafci","year":"2025","unstructured":"Lafci, O. et al. Role of imaging based response assesment for adapting neoadjuvant systemic therapy for breast cancer: a systematic review. Eur. J. Radio. 187, 112105 (2025).","journal-title":"Eur. J. Radio."},{"key":"995_CR66","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1245\/s10434-023-13367-w","volume":"30","author":"R Azam","year":"2023","unstructured":"Azam, R., Lim, D., Curpen, B., Mulligan, A.-M. & Hong, N. L. Correlation of mammographic microcalcifications with final surgical pathology after neoadjuvant chemotherapy for breast cancer. Ann. Surg. Oncol. 30, 4123\u20134131 (2023).","journal-title":"Ann. Surg. Oncol."},{"key":"995_CR67","doi-asserted-by":"publisher","first-page":"585","DOI":"10.11622\/smedj.2017098","volume":"58","author":"EJ Tan","year":"2017","unstructured":"Tan, E. J., Moey, T., Madhukumar, P. & Leong, L. C. Clinics in diagnostic imaging (180). Ductal carcinoma in situ (DCIS). Singapore Med. J. 58, 585\u2013592 (2017).","journal-title":"Singapore Med. J."},{"key":"995_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6485-4","volume":"19","author":"I Skarping","year":"2019","unstructured":"Skarping, I. et al. Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer. BMC Cancer 19, 1272 (2019).","journal-title":"BMC Cancer"},{"key":"995_CR69","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s10552-020-01379-w","volume":"32","author":"I Skarping","year":"2021","unstructured":"Skarping, I. et al. Mammographic density as an image-based biomarker of therapy response in neoadjuvant-treated breast cancer patients. Cancer Causes Control 32, 251\u2013260 (2021).","journal-title":"Cancer Causes Control"},{"key":"995_CR70","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s10549-022-06616-1","volume":"194","author":"C Cullinane","year":"2022","unstructured":"Cullinane, C. et al. The association between breast density and breast cancer pathological response to neoadjuvant chemotherapy. Breast Cancer Res. Treat. 194, 385\u2013392 (2022).","journal-title":"Breast Cancer Res. Treat."},{"key":"995_CR71","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3348\/kjr.2022.0629","volume":"24","author":"JH Ahn","year":"2023","unstructured":"Ahn, J. H. et al. Changes in automated mammographic breast density can predict pathological response after neoadjuvant chemotherapy in breast cancer. Korean J. Radiol. 24, 384\u2013394 (2023).","journal-title":"Korean J. Radiol."},{"key":"995_CR72","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1007\/s00330-020-06830-9","volume":"30","author":"HJ Jang","year":"2020","unstructured":"Jang, H. J. et al. Effect of neoadjuvant chemotherapy on breast tissue composition: a longitudinal mammographic study with automated volumetric measurement. Eur. Radiol. 30, 4785\u20134794 (2020).","journal-title":"Eur. Radiol."},{"key":"995_CR73","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ejrad.2018.09.032","volume":"108","author":"J Park","year":"2018","unstructured":"Park, J. et al. Comparison of mammography, digital breast tomosynthesis, automated breast ultrasound, magnetic resonance imaging in evaluation of residual tumor after neoadjuvant chemotherapy. Eur. J. Radiol. 108, 261\u2013268 (2018).","journal-title":"Eur. J. Radiol."},{"key":"995_CR74","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1200\/JCO.22.02819","volume":"42","author":"BK Patel","year":"2024","unstructured":"Patel, B. K. et al. Prospective study of supplemental screening with contrast-enhanced mammography in women with elevated risk of breast cancer: results of the prevalence round. J. Clin. Oncol. 42, 3826\u20133836 (2024).","journal-title":"J. Clin. Oncol."},{"key":"995_CR75","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1148\/radiol.2021201948","volume":"299","author":"MS Jochelson","year":"2021","unstructured":"Jochelson, M. S. & Lobbes, M. B. I. Contrast-enhanced mammography: state of the art. Radiology 299, 36\u201348 (2021).","journal-title":"Radiology"},{"key":"995_CR76","doi-asserted-by":"publisher","first-page":"884","DOI":"10.2214\/AJR.22.27756","volume":"219","author":"D Bernardi","year":"2022","unstructured":"Bernardi, D. et al. Contrast-enhanced mammography versus MRI in the evaluation of neoadjuvant therapy response in patients with breast cancer: a prospective study. Am. J. Roentgenol. 219, 884\u2013894 (2022).","journal-title":"Am. J. Roentgenol."},{"key":"995_CR77","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10549-023-06865-8","volume":"198","author":"MP Hogan","year":"2023","unstructured":"Hogan, M. P. et al. Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatment. Breast Cancer Res. Treat. 198, 349\u2013359 (2023).","journal-title":"Breast Cancer Res. Treat."},{"key":"995_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-023-07034-7","volume":"202","author":"M Kaiyin","year":"2023","unstructured":"Kaiyin, M., Lingling, T., Leilei, T., Wenjia, L. & Bin, J. Head-to-head comparison of contrast-enhanced mammography and contrast-enhanced MRI for assessing pathological complete response to neoadjuvant therapy in patients with breast cancer: a meta-analysis. Breast Cancer Res. Treat. 202, 1\u20139 (2023).","journal-title":"Breast Cancer Res. Treat."},{"key":"995_CR79","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJMra2302038","volume":"388","author":"CJ Haug","year":"2023","unstructured":"Haug, C. J. & Drazen, J. M. Artificial intelligence and machine learning in clinical medicine, 2023. N. Engl. J. Med. 388, 1201\u20131208 (2023).","journal-title":"N. Engl. J. Med."},{"key":"995_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-025-00831-x","volume":"11","author":"X Wang","year":"2025","unstructured":"Wang, X. et al. Predicting short- to long-term breast cancer risk from longitudinal mammographic screening history. npj Breast Cancer 11, 118 (2025).","journal-title":"npj Breast Cancer"},{"key":"995_CR81","doi-asserted-by":"publisher","first-page":"111624","DOI":"10.1016\/j.ejrad.2024.111624","volume":"178","author":"D F\u00f6rnvik","year":"2024","unstructured":"F\u00f6rnvik, D., Borgquist, S., Larsson, M., Zackrisson, S. & Skarping, I. Deep learning analysis of serial digital breast tomosynthesis images in a prospective cohort of breast cancer patients who received neoadjuvant chemotherapy. Eur. J. Radiol. 178, 111624 (2024).","journal-title":"Eur. J. Radiol."},{"key":"995_CR82","doi-asserted-by":"publisher","first-page":"42","DOI":"10.2214\/AJR.21.26506","volume":"218","author":"JH Yoon","year":"2022","unstructured":"Yoon, J. H., Kim, E.-K., Kim, G. R., Han, K. & Moon, H. J. Mammographic surveillance after breast-conserving therapy: impact of digital breast tomosynthesis and artificial intelligence\u2013based computer-aided detection. Am. J. Roentgenol. 218, 42\u201351 (2022).","journal-title":"Am. J. Roentgenol."},{"key":"995_CR83","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1007\/s00330-023-10238-6","volume":"34","author":"L Cai","year":"2024","unstructured":"Cai, L. et al. Can multi-modal radiomics using pretreatment ultrasound and tomosynthesis predict response to neoadjuvant systemic treatment in breast cancer? Eur. Radiol. 34, 2560\u20132573 (2024).","journal-title":"Eur. Radiol."},{"key":"995_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.816297","volume":"12","author":"X Kong","year":"2022","unstructured":"Kong, X. et al. Advances in imaging in evaluating the efficacy of neoadjuvant chemotherapy for breast cancer. Front. Oncol. 12, 816297 (2022).","journal-title":"Front. Oncol."},{"key":"995_CR85","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1002\/jmri.27145","volume":"52","author":"B Reig","year":"2020","unstructured":"Reig, B., Heacock, L., Lewin, A., Cho, N. & Moy, L. Role of MRI to assess response to neoadjuvant therapy for breast cancer. J. Magn. Reson. Imaging 52, 1587\u20131606 (2020).","journal-title":"J. Magn. Reson. Imaging"},{"key":"995_CR86","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1148\/rg.2021200134","volume":"41","author":"B Reig","year":"2021","unstructured":"Reig, B. et al. Breast MRI for evaluation of response to neoadjuvant therapy. Radiographics 41, 665\u2013679 (2021).","journal-title":"Radiographics"},{"key":"995_CR87","doi-asserted-by":"crossref","unstructured":"JR, S. et al. Preoperative MRI, clinical examination, and mammography for residual disease and pathologic complete response after neoadjuvant chemotherapy for breast cancer: ACRIN 6657 trial. Am. J. Roentgenol. 210, 1376\u20131385 (2018).","DOI":"10.2214\/AJR.17.18323"},{"key":"995_CR88","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.clbc.2019.06.006","volume":"20","author":"RF Cattell","year":"2020","unstructured":"Cattell, R. F. et al. MRI volume changes of axillary lymph nodes as predictor of pathologic complete responses to neoadjuvant chemotherapy in breast cancer. Clin. Breast Cancer 20, 68\u201379.e61 (2020).","journal-title":"Clin. Breast Cancer"},{"key":"995_CR89","doi-asserted-by":"crossref","unstructured":"SY, K. et al. Dynamic contrast-enhanced breast MRI for evaluating residual tumor size after neoadjuvant chemotherapy. Radiology 289, 327\u2013334 (2018).","DOI":"10.1148\/radiol.2018172868"},{"key":"995_CR90","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.230269","volume":"310","author":"D Arefan","year":"2024","unstructured":"Arefan, D. et al. Assessment of background parenchymal enhancement at dynamic contrast-enhanced MRI in predicting breast cancer recurrence risk. Radiology 310, e230269 (2024).","journal-title":"Radiology"},{"key":"995_CR91","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/jmri.27557","volume":"54","author":"BC Musall","year":"2021","unstructured":"Musall, B. C. et al. Functional tumor volume by fast dynamic contrast-enhanced MRI for predicting neoadjuvant systemic therapy response in triple-negative breast cancer. J. Magn. Reson. Imaging 54, 251\u2013260 (2021).","journal-title":"J. Magn. Reson. Imaging"},{"key":"995_CR92","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.diii.2023.07.003","volume":"104","author":"Y Cao","year":"2023","unstructured":"Cao, Y. et al. Early prediction of pathologic complete response of breast cancer after neoadjuvant chemotherapy using longitudinal ultrafast dynamic contrast-enhanced MRI. Diag. Interv. Imaging 104, 605\u2013614 (2023).","journal-title":"Diag. Interv. Imaging"},{"key":"995_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-025-00839-3","volume":"11","author":"MS Guirguis","year":"2025","unstructured":"Guirguis, M. S. et al. Early tumor volume reduction by breast DCE MRI predicts pathologic complete response to neoadjuvant therapy in triple negative breast cancer. npj Breast Cancer 11, 129 (2025).","journal-title":"npj Breast Cancer"},{"key":"995_CR94","doi-asserted-by":"publisher","first-page":"e2329933","DOI":"10.2214\/AJR.23.29933","volume":"222","author":"RL Gullo","year":"2024","unstructured":"Gullo, R. L., Partridge, S. C., Shin, H. J., Thakur, S. B. & Pinker, K. Update on DWI for breast cancer diagnosis and treatment monitoring. Am. J. Roentgenol. 222, e2329933 (2024).","journal-title":"Am. J. Roentgenol."},{"key":"995_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52785-3","volume":"9","author":"NP Pereira","year":"2019","unstructured":"Pereira, N. P. et al. Diffusion-weighted magnetic resonance imaging of patients with breast cancer following neoadjuvant chemotherapy provides early prediction of pathological response\u2014a prospective study. Sci. Rep. 9, 16372 (2019).","journal-title":"Sci. Rep."},{"key":"995_CR96","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.breast.2020.06.001","volume":"53","author":"A Surov","year":"2020","unstructured":"Surov, A., Wienke, A. & Meyer, H. J. Pretreatment apparent diffusion coefficient does not predict therapy response to neoadjuvant chemotherapy in breast cancer. Breast 53, 59\u201367 (2020).","journal-title":"Breast"},{"key":"995_CR97","doi-asserted-by":"publisher","first-page":"S155","DOI":"10.1016\/j.acra.2021.01.023","volume":"29","author":"R Zhao","year":"2022","unstructured":"Zhao, R. et al. Nomogram for early prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using dynamic contrast-enhanced and diffusion-weighted MRI. Acad. Radiol. 29, S155\u2013S163 (2022).","journal-title":"Acad. Radiol."},{"key":"995_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-02886-3","volume":"19","author":"S Suo","year":"2021","unstructured":"Suo, S. et al. Diffusion-weighted MRI for predicting pathologic response to neoadjuvant chemotherapy in breast cancer: evaluation with mono-, bi-, and stretched-exponential models. J. Transl. Med. 19, 236 (2021).","journal-title":"J. Transl. Med."},{"key":"995_CR99","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.240288","volume":"313","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Time-dependent diffusion MRI helps predict molecular subtypes and treatment response to neoadjuvant chemotherapy in breast cancer. Radiology 313, e240288 (2024).","journal-title":"Radiology"},{"key":"995_CR100","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-025-01631-2","volume":"25","author":"X Chen","year":"2025","unstructured":"Chen, X. et al. Prediction of neoadjuvant chemotherapy efficacy in breast cancer: integrating multimodal imaging and clinical features. BMC Med. Imaging 25, 118 (2025).","journal-title":"BMC Med. Imaging"},{"key":"995_CR101","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.242969","volume":"316","author":"X Gong","year":"2025","unstructured":"Gong, X. et al. Comparing multi\u2013b-value diffusion MRI models for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer. Radiology 316, e242969 (2025).","journal-title":"Radiology"},{"key":"995_CR102","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202313485","volume":"63","author":"E Di Gregorio","year":"2024","unstructured":"Di Gregorio, E. et al. A magnetic resonance imaging-chemical exchange saturation transfer (MRI-CEST) method for the detection of water cycling across cellular membranes. Angew. Chem. Int. Ed. 63, e202313485 (2024).","journal-title":"Angew. Chem. Int. Ed."},{"key":"995_CR103","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/jmri.26645","volume":"50","author":"J Zhou","year":"2019","unstructured":"Zhou, J., Heo, H. Y., Knutsson, L., van Zijl, P. C. M. & Jiang, S. APT-weighted MRI: techniques, current neuro applications, and challenging issues. J. Magn. Reson. Imaging 50, 347\u2013364 (2019).","journal-title":"J. Magn. Reson. Imaging"},{"key":"995_CR104","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-018-0982-2","volume":"20","author":"E Krikken","year":"2018","unstructured":"Krikken, E. et al. Amide chemical exchange saturation transfer at 7 T: a possible biomarker for detecting early response to neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Res. 20, 51 (2018).","journal-title":"Breast Cancer Res."},{"key":"995_CR105","doi-asserted-by":"publisher","first-page":"e200155","DOI":"10.1148\/rycan.2021200155","volume":"3","author":"S Zhang","year":"2021","unstructured":"Zhang, S. et al. Assessment of early response to neoadjuvant systemic therapy in triple-negative breast cancer using amide proton transfer\u2013weighted chemical exchange saturation transfer MRI: a pilot study. Radiol. Imaging Cancer 3, e200155 (2021).","journal-title":"Radiol. Imaging Cancer"},{"key":"995_CR106","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.70052","volume":"38","author":"L Li","year":"2025","unstructured":"Li, L. et al. Specific APT and NOE imaging using DSP-CEST in humans at 3\u2009T. NMR Biomed. 38, e70052 (2025).","journal-title":"NMR Biomed."},{"key":"995_CR107","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.222830","volume":"308","author":"Z Shi","year":"2023","unstructured":"Shi, Z. et al. MRI-based quantification of intratumoral heterogeneity for predicting treatment response to neoadjuvant chemotherapy in breast cancer. Radiology 308, e222830 (2023).","journal-title":"Radiology"},{"key":"995_CR108","doi-asserted-by":"crossref","unstructured":"Zhang, J. et al. Deep-learning-based HER2 status assessment from multimodal breast cancer data predicts neoadjuvant therapy response. Nat. Biomed. Eng. 10, 1235\u20131246.","DOI":"10.1038\/s41551-025-01495-5"},{"key":"995_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103042","volume":"61","author":"A Bitencourt","year":"2020","unstructured":"Bitencourt, A. et al. MRI-based machine learning radiomics can predict HER2 expression level and pathologic response after neoadjuvant therapy in HER2 overexpressing breast cancer. EBioMedicine 61, 103042 (2020).","journal-title":"EBioMedicine"},{"key":"995_CR110","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.243824","volume":"316","author":"T Ramtohul","year":"2025","unstructured":"Ramtohul, T. et al. Posttreatment MRI to predict pathologic complete response of triple-negative breast cancer to neoadjuvant chemoimmunotherapy. Radiology 316, e243824 (2025).","journal-title":"Radiology"},{"key":"995_CR111","doi-asserted-by":"publisher","first-page":"7685","DOI":"10.1245\/s10434-022-12034-w","volume":"29","author":"C Li","year":"2022","unstructured":"Li, C. et al. A noninvasive tool based on magnetic resonance imaging radiomics for the preoperative prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer. Ann. Surg. Oncol. 29, 7685\u20137693 (2022).","journal-title":"Ann. Surg. Oncol."},{"key":"995_CR112","doi-asserted-by":"publisher","first-page":"9041","DOI":"10.1109\/JBHI.2025.3540574","volume":"29","author":"Y Gao","year":"2025","unstructured":"Gao, Y. et al. Multi-modal longitudinal representation learning for predicting neoadjuvant therapy response in breast cancer treatment. IEEE J. Biomed. Health Inform. 29, 9041\u20139050 (2025).","journal-title":"IEEE J. Biomed. Health Inform."},{"key":"995_CR113","doi-asserted-by":"publisher","DOI":"10.1148\/rycan.230009","volume":"5","author":"K-P Hwang","year":"2023","unstructured":"Hwang, K.-P. et al. A radiomics model based on synthetic MRI acquisition for predicting neoadjuvant systemic treatment response in triple-negative breast cancer. Radiol. Imaging Cancer 5, e230009 (2023).","journal-title":"Radiol. Imaging Cancer"},{"key":"995_CR114","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11547-023-01595-9","volume":"128","author":"P Lin","year":"2023","unstructured":"Lin, P. et al. Molecular hallmarks of breast multiparametric magnetic resonance imaging during neoadjuvant chemotherapy. Radiol. Med. 128, 171\u2013183 (2023).","journal-title":"Radiol. Med."},{"key":"995_CR115","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202413702","volume":"12","author":"YH Huang","year":"2025","unstructured":"Huang, Y. H. et al. Longitudinal MRI-driven multi-modality approach for predicting pathological complete response and B cell infiltration in breast cancer. Adv. Sci. 12, e2413702 (2025).","journal-title":"Adv. Sci."},{"key":"995_CR116","doi-asserted-by":"publisher","first-page":"21256","DOI":"10.1002\/cam4.6704","volume":"12","author":"J Duan","year":"2023","unstructured":"Duan, J. et al. Imaging-proteomic analysis for prediction of neoadjuvant chemotherapy responses in patients with breast cancer. Cancer Med. 12, 21256\u201321269 (2023).","journal-title":"Cancer Med."},{"key":"995_CR117","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1200\/JCO.23.00249","volume":"41","author":"IS Dayes","year":"2023","unstructured":"Dayes, I. S. et al. Impact of 18F-labeled fluorodeoxyglucose positron emission tomography-computed tomography versus conventional staging in patients with locally advanced breast cancer. J. Clin. Oncol. 41, 3909\u20133916 (2023).","journal-title":"J. Clin. Oncol."},{"key":"995_CR118","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1200\/JCO.21.01228","volume":"40","author":"N Louarn","year":"2022","unstructured":"Louarn, N. et al. First extensive analysis of 18F-labeled fluorodeoxyglucose positron emission tomography\u2013computed tomography in a large cohort of patients with HIV-associated Hodgkin lymphoma: baseline total metabolic tumor volume affects prognosis. J. Clin. Oncol. 40, 1346\u20131355 (2022).","journal-title":"J. Clin. Oncol."},{"key":"995_CR119","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.eururo.2022.04.031","volume":"82","author":"Y Loriot","year":"2022","unstructured":"Loriot, Y. et al. The GETUG SEMITEP trial: de-escalating chemotherapy in good-prognosis seminoma based on fluorodeoxyglucose positron emission tomography\/computed tomography. Eur. Urol. 82, 172\u2013179 (2022).","journal-title":"Eur. Urol."},{"key":"995_CR120","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.jacc.2019.06.050","volume":"74","author":"S San","year":"2019","unstructured":"San, S. et al. Prognostic value of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in infective endocarditis. J. Am. Coll. Cardiol. 74, 1031\u20131040 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"995_CR121","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1053\/j.semnuclmed.2012.02.003","volume":"42","author":"O Schillaci","year":"2012","unstructured":"Schillaci, O. Use of dual-point fluorodeoxyglucose imaging to enhance sensitivity and specificity. Semin. Nucl. Med. 42, 267\u2013280 (2012).","journal-title":"Semin. Nucl. Med."},{"key":"995_CR122","doi-asserted-by":"crossref","unstructured":"Alshaibani, N. et al. Accuracy of MRI versus PET\/CT in the prediction of treatment response to neoadjuvant chemotherapy in breast cancer. Cureus 16, e66114 (2024).","DOI":"10.7759\/cureus.66114"},{"key":"995_CR123","doi-asserted-by":"publisher","first-page":"48","DOI":"10.21037\/gs-2024-568","volume":"14","author":"C Ge","year":"2025","unstructured":"Ge, C., Shi, L. & Tan, Z. J. G. S. 18F-fluorodeoxyglucose positron emission tomography-computed tomography for predicting pathological complete response to neoadjuvant chemotherapeutic in breast cancer patients. Gland Surg. 14, 48\u201359 (2025).","journal-title":"Gland Surg."},{"key":"995_CR124","unstructured":"van Amstel, F. et al. Disease extent according to baseline [18F]fluorodeoxyglucose PET\/CT and molecular subtype: prediction of axillary treatment response after neoadjuvant systemic therapy for breast cancer. Br. J. Surg. 111, znae203 (2024)."},{"key":"995_CR125","doi-asserted-by":"crossref","unstructured":"Groheux, D. et al. FDG-PET\/CT and multimodal machine learning model prediction of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer. Cancers 17, 1249 (2025).","DOI":"10.3390\/cancers17071249"},{"key":"995_CR126","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1007\/s00259-024-06815-6","volume":"51","author":"C Oliveira","year":"2024","unstructured":"Oliveira, C. et al. Baseline [18F]FDG PET\/CT and MRI first-order breast tumor features do not improve pathological complete response prediction to neoadjuvant chemotherapy. Eur. J. Nucl. Med. Mol. Imaging 51, 3709\u20133718 (2024).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"995_CR127","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.2967\/jnumed.123.266079","volume":"64","author":"L Chen","year":"2023","unstructured":"Chen, L. et al. 68Ga-labeled fibroblast activation protein inhibitor PET\/CT for the early and late prediction of pathologic response to neoadjuvant chemotherapy in breast cancer patients: a prospective study. J. Nucl. Med. 64, 1899\u20131905 (2023).","journal-title":"J. Nucl. Med."},{"key":"995_CR128","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-024-01859-w","volume":"26","author":"N Sinevici","year":"2024","unstructured":"Sinevici, N. et al. A prospective study of HER3 expression pre and post neoadjuvant therapy of different breast cancer subtypes: implications for HER3 imaging therapy guidance. Breast Cancer Res. 26, 107 (2024).","journal-title":"Breast Cancer Res."},{"key":"995_CR129","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3390\/bios14100501","volume":"14","author":"X Chen","year":"2024","unstructured":"Chen, X., Li, Y., Su, J., Zhang, L. & Liu, H. Progression in near-infrared fluorescence imaging technology for lung cancer management. Biosensors 14, 501 (2024).","journal-title":"Biosensors"},{"key":"995_CR130","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004936","volume":"10","author":"H Kang","year":"2022","unstructured":"Kang, H., Kang, M.-W., Kashiwagi, S. & Choi, H. S. NIR fluorescence imaging and treatment for cancer immunotherapy. J. Immunother. Cancer 10, e004936 (2022).","journal-title":"J. Immunother. Cancer"},{"key":"995_CR131","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.addr.2020.06.012","volume":"167","author":"Y Ji","year":"2020","unstructured":"Ji, Y. et al. Near-infrared fluorescence imaging in immunotherapy. Adv. Drug Deliv. Rev. 167, 121\u2013134 (2020).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"995_CR132","doi-asserted-by":"publisher","first-page":"6088","DOI":"10.3390\/cancers13236088","volume":"13","author":"MA van Dam","year":"2021","unstructured":"van Dam, M. A. et al. Overview and future perspectives on tumor-targeted positron emission tomography and fluorescence imaging of pancreatic cancer in the era of neoadjuvant therapy. Cancers 13, 6088 (2021).","journal-title":"Cancers"},{"key":"995_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2025.104480","volume":"52","author":"C Ge","year":"2025","unstructured":"Ge, C. et al. Research progress of near-infrared fluorescence imaging in accurate theranostics in bladder cancer. Photodiagnosis Photodyn. Ther. 52, 104480 (2025)","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"995_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.101978","volume":"6","author":"J Wang","year":"2025","unstructured":"Wang, J. et al. Near-infrared fluorescence imaging with an MET-targeting probe for biopsy site selection in patients with oral potentially malignant disorders. Cell Rep. Med. 6, 101978 (2025).","journal-title":"Cell Rep. Med."},{"key":"995_CR135","doi-asserted-by":"publisher","first-page":"5964","DOI":"10.3390\/molecules29245964","volume":"29","author":"Y Ge","year":"2024","unstructured":"Ge, Y. & O\u2019Shea, D. F. Review of clinically assessed molecular fluorophores for intraoperative image guided surgery. Molecules 29, 5964 (2024).","journal-title":"Molecules"},{"key":"995_CR136","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1200\/JCO.22.00291","volume":"41","author":"JL Tanyi","year":"2023","unstructured":"Tanyi, J. L. et al. A phase III study of pafolacianine injection (OTL38) for intraoperative imaging of folate receptor\u2013positive ovarian cancer (Study 006). J. Clin. Oncol. 41, 276\u2013284 (2023).","journal-title":"J. Clin. Oncol."},{"key":"995_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.109098","volume":"129","author":"J Zhang","year":"2020","unstructured":"Zhang, J. et al. Efficacy of shear-wave elastography versus dynamic optical breast imaging for predicting the pathological response to neoadjuvant chemotherapy in breast cancer. Eur. J. Radiol. 129, 109098 (2020).","journal-title":"Eur. J. Radiol."},{"key":"995_CR138","doi-asserted-by":"publisher","first-page":"076011","DOI":"10.1117\/1.JBO.18.7.076011","volume":"18","author":"S Jiang","year":"2013","unstructured":"Jiang, S. et al. Pilot study assessment of dynamic vascular changes in breast cancer with near-infrared tomography from prospectively targeted manipulations of inspired end-tidal partial pressure of oxygen and carbon dioxide. J. Biomed. Opt. 18, 076011 (2013).","journal-title":"J. Biomed. Opt."},{"key":"995_CR139","doi-asserted-by":"publisher","first-page":"4822","DOI":"10.1158\/1078-0432.CCR-23-1593","volume":"29","author":"X Cao","year":"2023","unstructured":"Cao, X. et al. Near-infrared spectral tomography for predicting residual cancer burden during early-stage neoadjuvant chemotherapy for breast cancer. Clin. Cancer Res. 29, 4822\u20134829 (2023).","journal-title":"Clin. Cancer Res."},{"key":"995_CR140","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1364\/OL.562560","volume":"50","author":"Z Guo","year":"2025","unstructured":"Guo, Z., Yang, Y., Zhao, Y., Robinson, J. T. & Veeraraghavan, A. High spatial resolution diffuse optical tomography with directional information. Opt. Lett. 50, 3122\u20133125 (2025).","journal-title":"Opt. Lett."},{"key":"995_CR141","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10549-021-06239-y","volume":"188","author":"Q Zhu","year":"2021","unstructured":"Zhu, Q. et al. Early assessment window for predicting breast cancer neoadjuvant therapy using biomarkers, ultrasound, and diffuse optical tomography. Breast Cancer Res. Treat. 188, 615\u2013630 (2021).","journal-title":"Breast Cancer Res. Treat."},{"key":"995_CR142","doi-asserted-by":"publisher","first-page":"106933","DOI":"10.1016\/j.cmpb.2022.106933","volume":"222","author":"M Seong","year":"2022","unstructured":"Seong, M., Oh, Y., Lee, K. & Kim, J. G. Blood flow estimation via numerical integration of temporal autocorrelation function in diffuse correlation spectroscopy. Comput. Methods Prog. Biomed. 222, 106933 (2022).","journal-title":"Comput. Methods Prog. Biomed."},{"key":"995_CR143","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-016-0008","volume":"1","author":"SH Yun","year":"2017","unstructured":"Yun, S. H. & Kwok, S. J. J. Light in diagnosis, therapy and surgery. Nat. Biomed. Eng. 1, 0008 (2017).","journal-title":"Nat. Biomed. Eng."},{"key":"995_CR144","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.1088\/1361-6560\/aa6cef","volume":"62","author":"JM Cochran","year":"2017","unstructured":"Cochran, J. M. et al. Longitudinal optical monitoring of blood flow in breast tumors during neoadjuvant chemotherapy. Phys. Med. Biol. 62, 4637\u20134653 (2017).","journal-title":"Phys. Med. Biol."},{"key":"995_CR145","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-020-01262-1","volume":"22","author":"A Tank","year":"2020","unstructured":"Tank, A. et al. Diffuse optical spectroscopic imaging reveals distinct early breast tumor hemodynamic responses to metronomic and maximum tolerated dose regimens. Breast Cancer Res. 22, 29 (2020).","journal-title":"Breast Cancer Res."},{"key":"995_CR146","doi-asserted-by":"crossref","unstructured":"LM, J. et al. MRI to assess response after neoadjuvant chemotherapy in breast cancer subtypes: a systematic review and meta-analysis. npj Breast Cancer 8, 107 (2022).","DOI":"10.1038\/s41523-022-00475-1"},{"key":"995_CR147","first-page":"127","volume":"69","author":"WL Bi","year":"2019","unstructured":"Bi, W. L. et al. Artificial intelligence in cancer imaging: clinical challenges and applications. CA Cancer J. Clin. 69, 127\u2013157 (2019).","journal-title":"CA Cancer J. Clin."},{"key":"995_CR148","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1042\/ETLS20210246","volume":"5","author":"RW Pettit","year":"2021","unstructured":"Pettit, R. W., Fullem, R., Cheng, C. & Amos, C. I. Artificial intelligence, machine learning, and deep learning for clinical outcome prediction. Emerg. Top. Life Sci. 5, 729\u2013745 (2021).","journal-title":"Emerg. Top. Life Sci."},{"key":"995_CR149","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1002\/jum.16524","volume":"43","author":"A Abbasian Ardakani","year":"2024","unstructured":"Abbasian Ardakani, A. et al. Interpretation of artificial intelligence models in healthcare. J. Ultrasound Med. 43, 1789\u20131818 (2024).","journal-title":"J. Ultrasound Med."},{"key":"995_CR150","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1001\/jama.2022.10561","volume":"328","author":"MA Reyna","year":"2022","unstructured":"Reyna, M. A., Nsoesie, E. O. & Clifford, G. D. Rethinking algorithm performance metrics for artificial intelligence in diagnostic medicine. JAMA 328, 329\u2013330 (2022).","journal-title":"JAMA"},{"key":"995_CR151","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/jmri.28096","volume":"55","author":"C Qu","year":"2022","unstructured":"Qu, C. et al. Application of magnetic resonance imaging in neoadjuvant treatment of pancreatic ductal adenocarcinoma. J. Magn. Reson. Imaging 55, 1625\u20131632 (2022).","journal-title":"J. Magn. Reson. Imaging"},{"key":"995_CR152","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-01256-2","volume":"10","author":"X Huang","year":"2026","unstructured":"Huang, X. et al. Longitudinal MRI-based deep learning model for predicting pathological complete response in breast cancer: a multicenter, retrospective cohort study. npj Precis. Oncol. 10, 57 (2026).","journal-title":"npj Precis. Oncol."}],"container-title":["npj Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00995-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00995-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00995-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:03:18Z","timestamp":1791993798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41523-026-00995-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":152,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["995"],"URL":"https:\/\/doi.org\/10.1038\/s41523-026-00995-0","relation":{},"ISSN":["2374-4677"],"issn-type":[{"value":"2374-4677","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"132"}}